| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
20,430,000 |
| Market
Cap: |
1.37(B) |
| Last
Volume: |
2,387,520 |
Avg
Vol: |
2,380,888 |
| 52
Week Range: |
$38.04 - $69.69 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ANI Pharmaceuticals is a bio-pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Co.'s products include: Candesartan Hydrochlorothiazide, Fenofibrate, Fluvoxamine, Hydrocortisone Enema, Lithium Carbonate ER, Mesalamine, Propranolol ER, Terbutaline, and Vancomycin.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
250,132 |
394,694 |
1,191,358 |
1,409,424 |
| Total Sell Value |
$16,523,610 |
$24,268,720 |
$69,977,407 |
$78,350,476 |
| Total People Sold |
8 |
9 |
11 |
11 |
| Total Sell Transactions |
21 |
39 |
80 |
83 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Przybyl Arthur |
President and CEO |
• • – |
2014-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
135,544 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2014-01-02 |
4 |
D |
$19.41 |
$26,478 |
D/D |
(1,364) |
43,909 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
45,273 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2014-01-02 |
4 |
D |
$19.41 |
$109,561 |
D/D |
(5,644) |
123,405 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
129,049 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-12-26 |
4 |
D |
$16.89 |
$23,041 |
D/D |
(1,364) |
41,598 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-12-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
42,962 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-12-26 |
4 |
D |
$16.91 |
$95,439 |
D/D |
(5,644) |
116,910 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-12-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
122,554 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-12-18 |
4 |
D |
$15.09 |
$20,582 |
D/D |
(1,364) |
39,287 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
40,651 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-12-18 |
4 |
D |
$15.13 |
$85,385 |
D/D |
(5,644) |
110,415 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
116,059 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-12-11 |
4 |
D |
$14.73 |
$20,090 |
D/D |
(1,364) |
36,976 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
38,340 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-12-11 |
4 |
D |
$14.72 |
$83,075 |
D/D |
(5,644) |
103,920 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
109,564 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-12-04 |
4 |
D |
$13.01 |
$73,444 |
D/D |
(5,644) |
97,425 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
103,069 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-12-04 |
4 |
D |
$13.02 |
$17,754 |
D/D |
(1,364) |
34,665 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
36,029 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-11-27 |
4 |
D |
$14.59 |
$82,357 |
D/D |
(5,644) |
90,930 |
|
- |
|
| Przybyl Arthur |
President and CEO |
• • – |
2013-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,139 |
96,574 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-11-27 |
4 |
D |
$14.60 |
$19,920 |
D/D |
(1,364) |
32,354 |
|
- |
|
| Arnold Charlotte C. |
Chief Financial Officer |
• – – |
2013-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
3,675 |
33,718 |
|
- |
|
707 Records found
|
|
Page 19 of 29 |
|
|
0.14 (0.21%) 
